An interventional study of Psychoeducation in Bipolar Disorder, sponsored by Pamukkale University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-21.
Sponsored by Pamukkale University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 45 studies in Bipolar Disorder with a site in Turkey — 10 open to participants now, 11 under way, none of them phase 3. Bipolar Disorder · Turkey.
Among the 45 studies in Bipolar Disorder with a site in Turkey, this one is the 16th largest by planned enrollment of the 26 interventional ones that give a count, is one of 11 that started in 2025, is one of 18 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 26th registered.
1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →10 of the 45 studies in Bipolar Disorder with a site in Turkey are open now. Recruiting first, the newest first:
TC Erciyes University · Sites in Turkey
Ages 18+
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65
Medipol University · Sites in Turkey
Ages 18–65
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 55+ · Healthy volunteers
Çankırı Karatekin University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
45 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 11 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 46 is below the median of 64 across 1,282 interventional studies indexed under Bipolar Disorder.
Median enrollment 50 across the 26 interventional studies, 72 across the 19 observational. Of the 30 that completed or were terminated, 3 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 45 have an industry lead sponsor. The 10 most frequent:
Pamukkale University is the lead sponsor of 343 studies on the registry; 61 are open to participants now.
Pamukkale University has 2 studies filed under Bipolar Disorder — fewer than ten, so there is no comparison to draw.
7 of the studies in Bipolar Disorder with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07949994TC Erciyes UniversitySALUTOGENESIS MODEL | 2026-11-28 |
| NCT07534475Medipol UniversityVenous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT | 2026-11-30 |
| NCT07879118Biruni UniversityEffect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness | 2026-12 |
| NCT07740694Istanbul University - CerrahpasaEEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT | 2026-12 |
| NCT07679204Elazığ Mental Health and Diseases HospitalType D Personality and Life Satisfaction in Bipolar Disorder Type 2 and Major Depressive Disorder | 2026-12-24 |
Add all 7 to your calendar (.ics) → With an account.
Among the 45 studies in Bipolar Disorder with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study was designed to determine the effect of mindfulness-based psychoeducation applied to primary caregivers of individuals diagnosed with bipolar disorder on their mindfulness, caregiver burden, quality of life, and psychological resilience.
Bipolar disorder is a chronic mental illness characterized by alternating episodes of opposing mood states (mania/hypomania and depression) and euthymic periods. Providing continuous care to individuals diagnosed with bipolar disorder can be highly challenging. Considering factors such as medication management, hospital follow-ups, patient behavior during episodes, and their attitudes toward themselves and others, being a primary caregiver is a demanding responsibility. Caregivers may face challenges such as constant caregiving burden, social isolation, burnout, neglecting self-care, and ignoring their own need for help. However, due to their perceived obligation to prioritize the patient, they may find themselves without adequate support.
Psychiatric nurses should approach not only the chronically mentally ill patient but also their caregivers, who are integral parts of the patient's environment, from a holistic perspective. The home environment of the patient, and particularly the attitude of the family and primary caregiver, plays a significant role in the prevention of relapses. From this holistic point of view, psychoeducation programs are expected to increase caregivers' psychological resilience, quality of life, and mindfulness levels, while reducing their caregiving burden. Such outcomes are anticipated to not only benefit the caregiver and the patient but also strengthen the broader society, as they may contribute to the reduction of relapse rates. Consequently, this could positively impact the national economy by decreasing healthcare utilization. Protecting caregivers may also lead to a reduced need for healthcare services directed toward them.
Psychoeducation is one of the core roles of psychiatric nurses. The recognition and expansion of mindfulness-based psychoeducation practices in the field are expected to provide significant support to both patients and their families.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Mindfulness-based psychoeducation will be applied to the experimental group.There will be pre-test and post-tests.
Behavioral: Psychoeducation
Only pre-test and post-tests will be applied without any intervention.
Mindfulness Based Psychoeducation
The Descriptive Characteristics Form
The Descriptive Characteristics Form consists of 16 questions related to individuals' sociodemographic information and personal characteristics (Age, Gender, Marital Status, Educational Status, Employment Status, Income Level, Caregiving Support, Duration of Being the Primary Caregiver, Smoking and Alcohol Use, Hobby Status, Social Support Information). It is a data collection tool developed based on a literature review.
Time frame: 6 months
Zarit Burden Interview
The scale was developed by Zarit, Reever, and Bach-Peterson to measure caregiver burden.It is a scale that can be completed either by the caregivers themselves or through interviews conducted by the researcher. The scale uses a Likert-type rating system ranging from 0 to 4 (never, rarely, sometimes, quite frequently, nearly always). Scores on the scale range from 0 to 88. The items primarily focus on social and emotional aspects, and a higher total score indicates a greater level of burden or distress experienced by the caregiver.
Time frame: 6 months
The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36, Short Form-36 Health Survey)
The SF-36 Survey was developed by Ware and Sherbourne (1992) to assess quality of life.This scale is used to assess physical and mental health in individuals over the age of 14, whether they have various health conditions or are healthy. The SF-36 is a generic quality of life scale and provides a comprehensive evaluation. The scale consists of 36 items, which include: physical functioning (10 items), role limitations due to physical health problems (2 items), social functioning (2 items), role limitations due to emotional problems (3 items), mental health (5 items), vitality (4 items), bodily pain (2 items), general health perceptions (5 items), and perceived change in health status (1 item). Each item is evaluated individually and scored on a scale from 0 to 100.
Time frame: 6 months
Resilience Scale for Adults
The scale was developed by Friborg et al. (2003) to measure psychological resilience in adults. The scale consists of 33 items and 6 subscales: self-perception, perception of the future, structured style, social competence, family cohesion, and social resources. It is a 5-point Likert-type scale. The response options are scored as follows: 1 - Strongly Disagree, 2 - Disagree, 3 - Neutral, 4 - Agree, and 5 - Strongly Agree.
Time frame: 6 months
Mindful Attention Awareness Scale
The scale was developed by Brown and Ryan (2003) to measure the level of mindfulness and consists of 15 items.In the scale, each item is scored based on how frequently the individual experiences that specific situation. It is a 6-point Likert-type scale with the following response options: "Almost never: 6," "Very rarely: 5," "Rarely: 4," "Sometimes: 3," "Often: 2," and "Almost always: 1." The total score on the scale ranges from a minimum of 15 to a maximum of 90. Based on the total score, individuals scoring between 66 and 90 are considered to have a high level of mindfulness, scores between 41 and 65 indicate a moderate level, and scores of 40 or below reflect a low level of mindfulness.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Sep 2025, 4 months after the start.
Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 4 months is below that.
Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.